stockrowEton Pharmaceuticals, Inc. (ETON) vs Pacira BioSciences, Inc. (PCRX)
- Eton Pharmaceuticals, Inc. ETON 47.45 −6.45%
- Pacira BioSciences, Inc. PCRX 36.44 +0.11%
Eton Pharmaceuticals, Inc. and Pacira BioSciences, Inc. are both Drug Manufacturers Specialty & Generic companies. Eton Pharmaceuticals, Inc. and Pacira BioSciences, Inc. are of similar size ($1.5B and $1.4B). Eton Pharmaceuticals, Inc. trades at the lower P/E: 26.8× against 38.4×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 100.6% against 3.70%. Eton Pharmaceuticals, Inc. has the higher net margin (35.4% vs 5.08%) and the higher return on invested capital (46.8% vs 5.37%). Across the 22 metrics below, Eton Pharmaceuticals, Inc. leads on 12 and Pacira BioSciences, Inc. on 10.
Valuation
Profitability
| Metric | ETON | PCRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 69.15% | 0.00% | 53.51% |
| Operating margin | 28.84% | 4.81% | 0.00% |
| Net margin | 35.35% | 5.08% | (2.45%) |
| Free cash flow margin | 14.17% | 22.74% | 0.00% |
| Return on equity | 90.62% | 5.24% | (0.80%) |
| Return on assets | 38.10% | 3.02% | (1.67%) |
| Return on invested capital | 46.77% | 5.37% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack